$1.40
-0.005[-0.36%]
Last update: 9:30AM Get Real Time Here
Marinus Pharma
(NASDAQ:MRNS)Latest News for Marinus Pharma Stock (NASDAQ:MRNS)
Marinus Pharma Stock (NASDAQ: MRNS)
Categories: All
Monday, April 29, 2024
Wednesday, April 17, 2024
Tuesday, April 16, 2024
- Analysts Question Commercial Viability of Marinus' IV Ganaxolone After Interim Analysis MissVandana Singh - Apr 16, 2024, 2:45PM
- The Latest Analyst Ratings For Marinus PharmaBenzinga Insights - Apr 16, 2024, 1:00PM
- HC Wainwright & Co. Reiterates Buy on Marinus Pharma, Maintains $27 Price TargetBenzinga Newsdesk - Apr 16, 2024, 10:59AM
Monday, April 15, 2024
- RBC Capital Downgrades Marinus Pharma to Sector Perform, Lowers Price Target to $3Benzinga Newsdesk - Apr 15, 2024, 2:52PM
- S&P 500 Down Over 1%; US Retail Sales Increase 0.7% In MarchAvi Kapoor - Apr 15, 2024, 2:30PM
- Why Ultragenyx Pharmaceutical Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Monday's Mid-Day SessionAvi Kapoor - Apr 15, 2024, 2:11PM
- 12 Health Care Stocks Moving In Monday's Intraday SessionBenzinga Insights - Apr 15, 2024, 12:31PM
- Crude Oil Down 1%; Charles Schwab Sales Top EstimatesAvi Kapoor - Apr 15, 2024, 12:02PM
- Why Did Epilepsy/Seizure Focused-Marinus Pharmaceuticals Stock Hit 52-Week Low On Monday?Vandana Singh - Apr 15, 2024, 10:13AM
- Dow Jumps Over 300 Points; Goldman Sachs Posts Upbeat EarningsAvi Kapoor - Apr 15, 2024, 10:00AM
- Marinus Pharmaceuticals shares are trading lower after the company provided an update on the Phase 3 RAISE trial and reported preliminary Q1 financial results.Benzinga Newsdesk - Apr 15, 2024, 8:46AM
- Marinus Pharmaceuticals, Neumora Therapeutics And Other Big Stocks Moving Lower In Monday's Pre-Market SessionAvi Kapoor - Apr 15, 2024, 8:19AM
- 12 Health Care Stocks Moving In Monday's Pre-Market SessionBenzinga Insights - Apr 15, 2024, 8:07AM
- Marinus Pharma Reported Prelim ZTALMY (Ganaxolone) Q1 Net Product Revenue of $7.4M-$7.6M, Cash of $113.3MBenzinga Newsdesk - Apr 15, 2024, 7:38AM
- Trading Halt: Halt status updated at 7:25:00 AM ET: Quotation Resumption: News and Resumption TimesBenzinga Newsdesk - Apr 15, 2024, 7:25AM
- Marinus Pharma to Continue Phase 3 RAISE Trial of IV Ganaxolone for Severe Seizure Treatment, Advances with ZTALMY's Successful Launch, Eyes New Drug Application and Optimizes Cash RunwayBenzinga Newsdesk - Apr 15, 2024, 7:04AM
- Trading Halt: Halted at 6:55:00 a.m. ET - Trading Halt: Halt News PendingBenzinga Newsdesk - Apr 15, 2024, 6:55AM
Wednesday, April 10, 2024
Wednesday, March 27, 2024
Tuesday, March 26, 2024
Thursday, March 07, 2024
- The Medicines And Healthcare Products Regulatory Agency Has Approved The Medicine Ganaxolone As The First Anti-Seizure Medication In The UK To Treat Cyclin-Dependent Kinase-Like 5 Deficiency DisorderBenzinga Newsdesk - Mar 7, 2024, 12:39PM
- Oppenheimer Maintains Perform on Marinus Pharma, Maintains $9 Price TargetBenzinga Newsdesk - Mar 7, 2024, 8:04AM
Wednesday, March 06, 2024
Tuesday, March 05, 2024
- 12 Health Care Stocks Moving In Tuesday's After-Market SessionBenzinga Insights - Mar 5, 2024, 4:31PM
- Leverage Shares -3x Short Moderna (MRNA) ETP Securities: Q4 Earnings InsightsBenzinga Insights - Mar 5, 2024, 4:25PM
- Marinus Pharma Q4 2023 GAAP EPS $(0.740) Misses $(0.630) Estimate, Sales $7.190M Miss $8.015M EstimateBenzinga Newsdesk - Mar 5, 2024, 4:23PM
- Earnings Scheduled For March 5, 2024Benzinga Insights - Mar 5, 2024, 5:00AM
Monday, March 04, 2024
Thursday, February 08, 2024
Thursday, January 04, 2024
Tuesday, December 05, 2023
Wednesday, November 22, 2023
Monday, November 20, 2023
Wednesday, November 08, 2023
Tuesday, November 07, 2023
- Marinus Pharmaceuticals Now Expects 2023 ZTALMY Net Product Revenues Of $18.5M-$19M Vs Previous Guidance Of $17M-$18.5M; Cash Runway Projected Into Q4 2024Benzinga Newsdesk - Nov 7, 2023, 7:15AM
- Marinus Pharmaceuticals Initiates Global Access Program For ZTALMY (ganaxolone) Oral Suspension CVBenzinga Newsdesk - Nov 7, 2023, 7:09AM
- Marinus Pharma Q3 EPS $(0.61) Vs $1.89 Last Year, Sales $7.34M Beat $6.33M EstimateBenzinga Newsdesk - Nov 7, 2023, 7:08AM
- Earnings Scheduled For November 7, 2023Benzinga Insights - Nov 7, 2023, 6:34AM